{"title":"A change in seroprevalence of SARS-CoV-2 among healthcare professionals (HCPs) of tertiary care hospital of northern state of India","authors":"D. Kumar, S. Raina, S. Jaryal, Sushant Sharma","doi":"10.4103/AMJM.AMJM_43_21","DOIUrl":null,"url":null,"abstract":"Background: SARS-CoV-2 is being managed rigorously by healthcare professionals (HCPs) making them vulnerable to infection and pose risk for human resource management. Objective: The current study was done to assess the change in seroprevalence, suggesting recent SARS-CoV-2 among HCPs of a tertiary care health facility as per government guidelines. Materials and Methods: Two hospital-based surveys (phase 1: September 2020 to January 2021; phase 2: May to June 2021) were carried out to quantify change in seroprevalence of SARS-CoV-2 infection among HCPs. A total of 1279 and 765 HCPs were assessed in first and second phase accordingly. Out of 765, a total of 412 professionals were assessed for serum IgG antibody. Results: Seroprevalence increases from 12.7% to 31.1% from first to second phase of the study. The adjusted odds ratio (aOR) was found to be significantly high for residents [aOR: 3.57; 95% confidence interval (CI): 1.17–10.89], nurses (aOR: 3.54; 95% CI: 1.20–10.42), administrative (aOR: 8.18; 95% CI: 1.43–46.53), and laboratory staff (aOR: 6.03, 95% CI: 2.97–16.05). Adjusted odds were observed to be significantly more among participants positive for reverse transcriptase–polymerase chain reaction test (aOR: 6.90; 95% CI: 2.97–16.05) and positive for IgG in P1 (aOR: 2.59; 95% CI: 1.32–5.09). Discussion: HCPs mainly residents, nurses, hospital support, and laboratory staff are observed with increased SARS-CoV-2 infection from first to second phase of the study.","PeriodicalId":138060,"journal":{"name":"Amrita Journal of Medicine","volume":"17 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Amrita Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/AMJM.AMJM_43_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: SARS-CoV-2 is being managed rigorously by healthcare professionals (HCPs) making them vulnerable to infection and pose risk for human resource management. Objective: The current study was done to assess the change in seroprevalence, suggesting recent SARS-CoV-2 among HCPs of a tertiary care health facility as per government guidelines. Materials and Methods: Two hospital-based surveys (phase 1: September 2020 to January 2021; phase 2: May to June 2021) were carried out to quantify change in seroprevalence of SARS-CoV-2 infection among HCPs. A total of 1279 and 765 HCPs were assessed in first and second phase accordingly. Out of 765, a total of 412 professionals were assessed for serum IgG antibody. Results: Seroprevalence increases from 12.7% to 31.1% from first to second phase of the study. The adjusted odds ratio (aOR) was found to be significantly high for residents [aOR: 3.57; 95% confidence interval (CI): 1.17–10.89], nurses (aOR: 3.54; 95% CI: 1.20–10.42), administrative (aOR: 8.18; 95% CI: 1.43–46.53), and laboratory staff (aOR: 6.03, 95% CI: 2.97–16.05). Adjusted odds were observed to be significantly more among participants positive for reverse transcriptase–polymerase chain reaction test (aOR: 6.90; 95% CI: 2.97–16.05) and positive for IgG in P1 (aOR: 2.59; 95% CI: 1.32–5.09). Discussion: HCPs mainly residents, nurses, hospital support, and laboratory staff are observed with increased SARS-CoV-2 infection from first to second phase of the study.